tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GILD Stock Latest News

Gilead price target raised to $135 from $125 at Citi
The FlyGilead price target raised to $135 from $125 at Citi
23h ago
GILD
Gilead Sciences: Strategic Positioning and Extended Patent Protection Justify Buy Rating
PremiumRatings
Gilead Sciences: Strategic Positioning and Extended Patent Protection Justify Buy Rating
2d ago
GILD
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
PremiumThe Fly
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
3d ago
ABBV
GILD
Gilead Sciences Settles Patent Litigation on Biktarvy
PremiumCompany Announcements
Gilead Sciences Settles Patent Litigation on Biktarvy
3d ago
8K
GILD
Gilead settles patent litigations with Biktarvy ANDA filerers
PremiumThe Fly
Gilead settles patent litigations with Biktarvy ANDA filerers
3d ago
GILD
Gilead Sciences: Strategic Diversification and Promising Inflammation Pipeline Justify Buy Rating
PremiumRatingsGilead Sciences: Strategic Diversification and Promising Inflammation Pipeline Justify Buy Rating
3d ago
GILD
Gilead Sciences: Strong Growth Potential Driven by Yeztugo Launch and Strategic Positioning
Premium
Ratings
Gilead Sciences: Strong Growth Potential Driven by Yeztugo Launch and Strategic Positioning
6d ago
GILD
RBC sees 5% downside for Gilead if Trump referred to Biktarvy
Premium
The Fly
RBC sees 5% downside for Gilead if Trump referred to Biktarvy
8d ago
GILD
Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
PremiumThe Fly
Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
17d ago
BMY
GSK
Optimistic Growth Outlook for Gilead Sciences Driven by Yeztugo’s Market Potential and CDC Endorsement
PremiumRatings
Optimistic Growth Outlook for Gilead Sciences Driven by Yeztugo’s Market Potential and CDC Endorsement
17d ago
GILD
Nurix Therapeutics presents data from GS-6791
PremiumThe Fly
Nurix Therapeutics presents data from GS-6791
22d ago
GILD
NRIX
Buy Recommendation for Gilead Sciences Amid Strategic Positioning and Legal Developments
PremiumRatings
Buy Recommendation for Gilead Sciences Amid Strategic Positioning and Legal Developments
23d ago
GILD
Gilead price target raised to $145 from $135 at JPMorgan
PremiumThe FlyGilead price target raised to $145 from $135 at JPMorgan
23d ago
GILD
RBC lists biotech winners should RFK depart HHS
Premium
The Fly
RBC lists biotech winners should RFK depart HHS
29d ago
ALKS
AXSM
RBC lists biotech winners should RFK departure HHS
Premium
The Fly
RBC lists biotech winners should RFK departure HHS
29d ago
ALKS
AXSM
Veeva receives another Top 20 Vault CRM commitment, says Raymond James
PremiumThe Fly
Veeva receives another Top 20 Vault CRM commitment, says Raymond James
29d ago
CRM
GILD
Veeva says Gilead commits to Veeva Vault CRM
PremiumThe Fly
Veeva says Gilead commits to Veeva Vault CRM
29d ago
GILD
VEEV
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
PremiumThe Fly
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
30d ago
XLO
GILD
Gilead Sciences Advances GS-4321 Study for Chronic Hepatitis Delta
PremiumCompany Announcements
Gilead Sciences Advances GS-4321 Study for Chronic Hepatitis Delta
1M ago
GILD
Gilead Sciences Advances Pediatric HIV Treatment with New Study Update
PremiumCompany AnnouncementsGilead Sciences Advances Pediatric HIV Treatment with New Study Update
1M ago
GILD
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study
Premium
Company Announcements
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study
1M ago
GILD
Gilead Sciences’ Seladelpar Study: A Promising Step in PBC Treatment
Premium
Company Announcements
Gilead Sciences’ Seladelpar Study: A Promising Step in PBC Treatment
1M ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >